Over the past 12 months, $ABBV has generated 46 mentions from 7 distinct FinTwit voices, with discussion concentrated among biotech-focused accounts. @jacobplieth leads engagement with 37 mentions, followed by @adamfeuerstein with 11 mentions, while @tradableastro, @alphaticaio, and @jasonl_capital each contributed 1-2 mentions. The first mention appeared on 2025-08-25, with activity continuing through 2026-07-17.

Recent discussion centered on AbbVie's acquisition activity and pipeline developments. In June 2026, @adamfeuerstein and @alphaticaio discussed the company's $10.9 billion acquisition of Apogee Therapeutics, with the deal announced as expected. Most recently, @jacobplieth compared various in vivo CAR-T therapeutic approaches across multiple companies including $ABBV alongside $LLY, $AZN, $RNAC, and $BMY on 2026-07-17.